Calcium silicate/bortezomib combinatory therapy for multiple myeloma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Calcium silicate/bortezomib combinatory therapy for multiple myeloma
Authors
Keywords
-
Journal
Journal of Materials Chemistry B
Volume -, Issue -, Pages -
Publisher
Royal Society of Chemistry (RSC)
Online
2023-02-06
DOI
10.1039/d2tb02009b
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnosis and Management of Multiple Myeloma
- (2022) Andrew J. Cowan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pathogenic signaling in multiple myeloma
- (2022) Arnold Bolomsky et al. SEMINARS IN ONCOLOGY
- Multiple myeloma: 2022 update on diagnosis, risk stratification, and management
- (2022) S. Vincent Rajkumar AMERICAN JOURNAL OF HEMATOLOGY
- Silicate ions as soluble form of bioactive ceramics alleviate aortic aneurysm and dissection
- (2022) Yumei Que et al. Bioactive Materials
- Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy
- (2021) Shota Yamamoto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling
- (2021) Zhipeng Su et al. Cell Death & Disease
- NF-κB–dependent IRF1 activation programs cDC1 dendritic cells to drive antitumor immunity
- (2021) Ghita Ghislat et al. Science Immunology
- Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics
- (2021) Tao Chen et al. Bioactive Materials
- Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
- (2020) Shaji K. Kumar et al. Journal of the National Comprehensive Cancer Network
- Subcutaneous bortezomib might be standard of care for patients with multiple myeloma: a systematic review and meta-analysis
- (2019) Ziqi Ye et al. Drug Design Development and Therapy
- Bortezomib-containing therapy in Japanese children with relapsed acute lymphoblastic leukemia
- (2019) Daisuke Hasegawa et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- CCL2 promotes macrophages-associated chemoresistance via MCPIP1 dual catalytic activities in multiple myeloma
- (2019) Ruyi Xu et al. Cell Death & Disease
- Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
- (2019) Silpa Narayanan et al. DRUG RESISTANCE UPDATES
- Regulation of immune response by bioactive ions released from silicate bioceramics for bone regeneration
- (2018) Yan Huang et al. Acta Biomaterialia
- Clinical Pharmacokinetics and Pharmacodynamics of Bortezomib
- (2018) Carlyn Rose C. Tan et al. CLINICAL PHARMACOKINETICS
- Chitosan/Calcium Silicate Cardiac Patch Stimulates Cardiomyocyte Activity and Myocardial Performance after Infarction by Synergistic Effect of Bioactive Ions and Aligned Nanostructure
- (2018) Xiaotong Wang et al. ACS Applied Materials & Interfaces
- The impact of NF-κB signaling on pathogenesis and current treatment strategies in multiple myeloma
- (2018) Dávid Vrábel et al. BLOOD REVIEWS
- Ion Therapy: A Novel Strategy for Acute Myocardial Infarction
- (2018) Min Yi et al. Advanced Science
- BAFF is involved in macrophage-induced bortezomib resistance in myeloma
- (2017) Jing Chen et al. Cell Death & Disease
- Selective cytotoxicity of vanadium complexes on human pancreatic ductal adenocarcinoma cell line by inducing necroptosis, apoptosis and mitotic catastrophe process
- (2017) Szymon Kowalski et al. Oncotarget
- Multiple myeloma
- (2017) Shaji K. Kumar et al. Nature Reviews Disease Primers
- Pathobiology and Diagnosis of Multiple Myeloma
- (2017) Kevin Brigle et al. Seminars in Oncology Nursing
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Age-Associated Sirtuin 1 Reduction in Vascular Smooth Muscle Links Vascular Senescence and Inflammation to Abdominal Aortic AneurysmNovelty and Significance
- (2016) Hou-Zao Chen et al. CIRCULATION RESEARCH
- Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial
- (2015) M. Merz et al. HAEMATOLOGICA
- Stimulation of apoptotic pathways in liver cancer cells: An alternative perspective on the biocompatibility and the utility of biomedical glasses
- (2015) Nancy Kilcup et al. JOURNAL OF BIOMATERIALS APPLICATIONS
- Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial
- (2015) M. Merz et al. HAEMATOLOGICA
- Bortezomib in multiple myeloma: systematic review and clinical considerations
- (2014) T.C. Kouroukis et al. Current Oncology
- Good clinical activity and favorable toxicity profile of once weekly bortezomib, fotemustine, and dexamethasone (B-MuD) for the treatment of relapsed multiple myeloma
- (2012) Silvia Mangiacavalli et al. AMERICAN JOURNAL OF HEMATOLOGY
- NF-κB and the link between inflammation and cancer
- (2012) Joseph A. DiDonato et al. IMMUNOLOGICAL REVIEWS
- Effects of Wollastonite on Proliferation and Differentiation of Human Bone Marrow-derived Stromal Cells in PHBV/Wollastonite Composite Scaffolds
- (2008) Haiyan Li et al. JOURNAL OF BIOMATERIALS APPLICATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started